PMC:7074424 / 11125-11251 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"233","span":{"begin":92,"end":95},"obj":"Gene"},{"id":"247","span":{"begin":6,"end":14},"obj":"Species"}],"attributes":[{"id":"A233","pred":"tao:has_database_id","subj":"233","obj":"Gene:4283"},{"id":"A247","pred":"tao:has_database_id","subj":"247","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"1UK4 SARS-CoV 3CLPro and its interactions with an inhibitor Substrate analog hexapeptidyl CMK inhibitor IC50 ca. 2 mM [34]"}

{"project":"2_test","denotations":[{"id":"32201449-14585926-47217031","span":{"begin":123,"end":125},"obj":"14585926"},{"id":"T19390","span":{"begin":123,"end":125},"obj":"14585926"}],"text":"1UK4 SARS-CoV 3CLPro and its interactions with an inhibitor Substrate analog hexapeptidyl CMK inhibitor IC50 ca. 2 mM [34]"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T45","span":{"begin":6,"end":14},"obj":"Disease"},{"id":"T46","span":{"begin":6,"end":10},"obj":"Disease"}],"attributes":[{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"1UK4 SARS-CoV 3CLPro and its interactions with an inhibitor Substrate analog hexapeptidyl CMK inhibitor IC50 ca. 2 mM [34]"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T100","span":{"begin":92,"end":95},"obj":"http://purl.obolibrary.org/obo/CLO_0002526"},{"id":"T101","span":{"begin":123,"end":125},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"}],"text":"1UK4 SARS-CoV 3CLPro and its interactions with an inhibitor Substrate analog hexapeptidyl CMK inhibitor IC50 ca. 2 mM [34]"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T91","span":{"begin":51,"end":60},"obj":"Chemical"},{"id":"T92","span":{"begin":96,"end":105},"obj":"Chemical"}],"attributes":[{"id":"A91","pred":"chebi_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A92","pred":"chebi_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"1UK4 SARS-CoV 3CLPro and its interactions with an inhibitor Substrate analog hexapeptidyl CMK inhibitor IC50 ca. 2 mM [34]"}

{"project":"LitCovid-sentences","denotations":[{"id":"T70","span":{"begin":0,"end":115},"obj":"Sentence"},{"id":"T71","span":{"begin":116,"end":126},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"1UK4 SARS-CoV 3CLPro and its interactions with an inhibitor Substrate analog hexapeptidyl CMK inhibitor IC50 ca. 2 mM [34]"}